TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?

Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff

Research output: Contribution to journalArticlepeer-review

Abstract

TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a critical factor enabling cellular infection by coronaviruses, including SARS-CoV-2. The modulation of its expression by sex steroids could contribute to the male predominance of severe infections, and given that TMPRSS2 has no known indispensable functions, and inhibitors are available, it is an appealing target for prevention or treatment of respiratory viral infections.

Original languageEnglish (US)
Pages (from-to)779-782
Number of pages4
JournalCancer discovery
Volume10
Issue number6
DOIs
StatePublished - Jun 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?'. Together they form a unique fingerprint.

Cite this